End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,920 KRW | -2.29% | +2.18% | +5.61% |
Apr. 05 | Enzychem Lifesciences Corporation announces an Equity Buyback for KRW 10,000 million worth of its shares. | CI |
Apr. 05 | Enzychem Lifesciences Corporation authorizes a Buyback Plan. | CI |
Sales 2022 | 26.64B 19.37M | Sales 2023 | 76.04B 55.28M | Capitalization | 155B 112M |
---|---|---|---|---|---|
Net income 2022 | -25.09B -18.24M | Net income 2023 | -9.33B -6.78M | EV / Sales 2022 | -0.58 x |
Net cash position 2022 | 155B 113M | Net cash position 2023 | 132B 95.74M | EV / Sales 2023 | 0.3 x |
P/E ratio 2022 |
-5.24
x | P/E ratio 2023 |
-16.5
x | Employees | 113 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.03% |
1 day | -2.29% | ||
1 week | +2.18% | ||
1 month | -4.00% | ||
3 months | +13.61% | ||
6 months | +20.68% | ||
Current year | +5.61% |
Managers | Title | Age | Since |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 12-05-31 |
Do-Hyeon Jo
COO | Chief Operating Officer | 49 | 16-10-20 |
Myung-Hwan Kim
BRD | Director/Board Member | 67 | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 12-05-31 |
Hye-Kyung Kim
BRD | Director/Board Member | 66 | 12-06-30 |
Jae-Yong Lee
BRD | Director/Board Member | 62 | 11-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1,920 | -2.29% | 436,724 |
24-05-30 | 1,965 | +2.56% | 548,664 |
24-05-29 | 1,916 | -1.44% | 451,250 |
24-05-28 | 1,944 | +4.35% | 675,882 |
24-05-27 | 1,863 | -0.85% | 312,831 |
End-of-day quote Korea S.E., May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+5.61% | 118M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- A183490 Stock